Advertisement

Neurocognitive disorders in DSM 5 project — Personal comments

  • Ovidiu Bajenaru
    Correspondence
    Corresponding author at: University Emergency Hospital Bucharest, Department of Neurology, Splaiul Independentei 169, sectorul 5, RO-050098 Bucharest, Romania. Tel.: +40 21 318 05 02; fax: +40 21 312 81 02.
    Affiliations
    University of Medicine and Pharmacy “Carol Davila” Bucharest, Faculty of Medicine, Department of Neurology, Neurosurgery and Psychiatry, Romania

    University Emergency Hospital Bucharest, Department of Neurology, Romania
    Search for articles by this author
  • Cristina Tiu
    Affiliations
    University of Medicine and Pharmacy “Carol Davila” Bucharest, Faculty of Medicine, Department of Neurology, Neurosurgery and Psychiatry, Romania

    University Emergency Hospital Bucharest, Department of Neurology, Romania
    Search for articles by this author
  • Florina Antochi
    Affiliations
    University Emergency Hospital Bucharest, Department of Neurology, Romania
    Search for articles by this author
  • Adina Roceanu
    Affiliations
    University Emergency Hospital Bucharest, Department of Neurology, Romania
    Search for articles by this author
Published:August 20, 2012DOI:https://doi.org/10.1016/j.jns.2012.07.067

      Abstract

      The actual criteria for diagnosis of dementia have many shortages, due to the fact that both DSM 4 and ICD 10 criteria are essentially based on the typical evolution of Alzheimer's disease, which is the most frequent, but not the only one cause of dementia in the general population. In the new project of DSM-5, proposed for public debate by the American Psychiatric Association (APA), new criteria for neurocognitive disorders are defined which seem more suitable to cover in a much more appropriate way all the entities potentially leading to dementia. In our view, these new criteria are also in line with the updated knowledge about these diseases as they are reflected in the recent publications and recommendations of international experts and medical associations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dubois B.
        • Feldman H.H.
        • Jacova C.
        • Cummings J.L.
        • DeKosky S.T.
        • Barberger-Gateau P.
        • et al.
        Revising the definition of Alzheimer's disease: a new lexicon.
        Lancet Neurol. 2010; 9: 1118-1127
        • American Psychiatric Association
        The future of psychiatric diagnosis DSM-5.
        • Braak H.
        • Braak E.
        Neuropathological stageing of Alzheimer-related changes.
        Acta Neuropathol (Berl). 1991; 82: 239-259
        • Delacourte A.
        • David J.P.
        • Sergeant N.
        • Buée L.
        • Wattez A.
        • Vermersch P.
        • et al.
        The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
        Neurology. 1999; 52: 1158-1165
        • Dubois B.
        • Feldman H.H.
        • Jacova C.
        • Cummings J.L.
        • DeKosky S.T.
        • Barberger-Gateau P.
        • et al.
        Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS—ADRDA criteria.
        Lancet Neurol. 2007; 6: 734-746
        • Frisoni G.B.
        • Fox N.C.
        • Jack Jr., C.R.
        • Scheltens P.
        • Thompson P.M.
        The clinical use of structural MRI in Alzheimer disease.
        Nat Rev Neurol. 2010; 6: 67-77
        • Jack Jr., C.R.
        • Albert M.S.
        • Knopman D.S.
        • McKhann G.M.
        • Sperling R.A.
        • Carrillo M.C.
        • et al.
        Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. 2011; 7: 257-262
        • McKhann G.M.
        • Knopman D.S.
        • Chertkow Howard
        • Hyman B.T.
        • Jack Jr., C.R.
        • Kawas Claudia H.
        • et al.
        The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. 2011; 7: 263-269
        • Albert M.S.
        • DeKosky S.T.
        • Dickson D.
        • Dubois B.
        • Feldman H.H.
        • Fox N.C.
        • et al.
        The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. 2011; 7: 270-279
        • Sperling R.A.
        • Aisen P.S.
        • Beckett L.A.
        • Bennett D.A.
        • Craft S.
        • Fagan A.M.
        • et al.
        Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. 2011; 7: 280-292
        • Kivipelto M.
        • Solomon A.
        Preventive neurology: on the way from knowledge to action.
        Neurology. 2009; 73: 168-169